Lv11
50 积分 2025-12-05 加入
Probing cancer with small-molecule tools—Progress and challenges
1天前
已完结
Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer
1天前
已完结
Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer
1个月前
已完结
Plasma proteomics profiling identifies predictive biomarkers for immunotherapy response in small-cell lung cancer
1个月前
已关闭
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
1个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
2个月前
已完结
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
2个月前
已完结
Advancements in small cell lung cancer
3个月前
已完结
皖公网安备34019202002308
